retatrutide phase 2 results obesity nejm 2023 GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Retatrutide Week by Week: Weight

10.2147/DMSO.S528569 108 PintoL

Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort

Not because patches are automatically bad, but because the specific story Lipovia tells raises key trust issues: It implies GLP-1-like results without offering the kind of evidence you would expect for that level of claim

Bellavance D, et al

Some people are needle anxious, some dislike the medical feeling of injecting and others simply prefer the discretion of taking a tablet. Who can use it

Although some plans may exclude GLP-1s for weight loss, they might approve them for diabetes or sleep apnea